Skip to main content
    M

    Minerva Neurosciences Inc (NERV)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.20
    -0.10 (-4.35%)

    Market Cap: $114.62M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    51%(19/37)
    Avg Surprise
    +4.69%

    Upcoming Estimates

    Reports Mar 9, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.14
    Range-$0.24 - -$0.01
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.09
    Range-$0.09 - -$0.09
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.11+18.2%
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current-$0.09
    Revenue Consensus
    N/A
    RangeN/A
    2 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-675.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage1.04x
    Current Ratio33.02xQuick Ratio33.02x
    Trading Statistics
    Beta0.01Avg Volume190.66K
    52-Week High$8.8052-Week Low$1.96

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 25.8% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 37.8, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$2.42
    SMA 20$2.37
    SMA 50$2.97
    SMA 200$4.80
    EMA 10$2.38
    EMA 20$2.47
    EMA 50$2.93
    EMA 200$3.94

    MACD

    Line: -0.16Signal: -0.20Hist: 0.04

    ADX

    ADX: 20.0+DI: 18.2-DI: 23.9

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down56.0
    PSAR$2.75

    Bollinger Bands

    Upper Band$2.63
    Lower Band$2.11
    %B Position2211%(Upper)
    Band Width0.18

    RSI (14-Day)

    Neutral
    37.8

    Momentum Oscillators

    Stoch %K41.7
    Stoch %D54.3
    Williams %R-70.0
    ROC (10d)-6.2%
    Momentum-0.14
    CCI (20d)-102.6
    MFI (14d)44.4

    Volatility Measures

    ATR (14d)$0.24(11.0%)
    StdDev (20d)0.13
    Hist Vol88.0%(High)

    Volume Flow

    VWAP$2.23
    OBV178.3M
    AD Line-143.5M
    CMF (20d)-0.050

    Volume Metrics

    Avg Vol (20d)194.3K
    Vol Ratio0.7x
    VWMA (20d)$2.38

    Pivot Points

    R3$2.52
    R2$2.46
    R1$2.38
    Pivot Point$2.32
    S1$2.24
    S2$2.18
    S3$2.10

    Advanced Oscillators

    TSI-20.55
    Ultimate Osc50.6
    KST-152.80

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about NERV

    News

    NERV Valuation

    Minerva Neurosciences (NERV) trades at 11.2x forward earnings.

    Forward P/E
    11.2x
    P/B
    -1.1x
    All NERV metrics

    NERV Profitability: Margins, ROIC and FCF

    Minerva Neurosciences (NERV) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -675.0%
    NERV financial statements

    Minerva Neurosciences Competitors

    The companies most similar to Minerva Neurosciences (NERV) include Neumora Therapeutics, NRX Pharmaceuticals and LENZ Therapeutics.

    Sector: Healthcare

    Companies most similar to Minerva Neurosciences

    NERV Analyst Ratings

    Minerva Neurosciences (NERV) has a Buy consensus from 3 analysts: 2 Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    1
    Buy
    1
    Hold
    1
    Sell
    0
    Strong Sell
    0
    NERV stock forecast

    NERV Earnings: Beat Rate and Next Report

    Minerva Neurosciences (NERV) beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate (62.5%). Its next report is expected on Mar 9, 2027.

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    64.2%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.14
    NERV earnings history

    NERV Earnings Date

    NERV reports Mar 9, 2027. The date is estimated.

    NERV ETF Holders

    See insider activity

    Updated Nov 6, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About NERV

    When does NERV report earnings?

    Minerva Neurosciences Inc (NERV) is expected to report earnings on Mar 9, 2027.

    Does NERV pay dividends?

    Minerva Neurosciences Inc (NERV) does not currently pay a regular dividend.

    What is NERV's market cap?

    Minerva Neurosciences Inc (NERV) has a market capitalization of $114.62M with a current stock price of $2.20.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.